<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Fennec Pharmaceuticals Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Fennec Pharmaceuticals Inc.

    Fennec Pharmaceuticals, Inc., (NASDAQ: FENC; TSX: FRX) is a specialty pharmaceutical company focused on the development of PEDMARKTM (a unique formulation of sodium thiosulfate (STS)) for the prevention of platinum-induced ototoxicity in pediatric patients. STS has received Orphan Drug Designation in the US in this setting. Fennec has completed two pediatric phase 3 studies and plans to file for approval of PEDMARKTM in 2018. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Rostislav Raykov
    • FOUNDED
      1996
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Evofem Biosciences, Inc.

    Evofem Biosciences, Inc.

    Evofem BiosciencesÂŽ exists to advance the lives of women. We believe this work ce...

    Evofem BiosciencesÂŽ exists to advance the live...

    Filing Type:    PU
    ICU Medical, Inc.

    ICU Medical, Inc.

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manufactures and sells innovative medica...

    ICU Medical, Inc. (Nasdaq:ICUI) develops, manuf...

    Filing Type:    PU
    Viking Therapeutics, Inc.

    Viking Therapeutics, Inc.

    Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the d...

    Viking Therapeutics is a clinical-stage biophar...

    Filing Type:    PU
    Veru Inc.

    Veru Inc.

    Our strategy is to be known as “the prostate cancer company”. We aspire to be ...

    Our strategy is to be known as “the prostate ...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Epizyme, Inc.

    Epizyme, Inc.

    Epizyme, Inc. is a clinical stage biopharmaceutical company creating novel epigene...

    Epizyme, Inc. is a clinical stage biopharmaceut...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.